Sandra Ferreyra Vega

453 total citations
13 papers, 252 citations indexed

About

Sandra Ferreyra Vega is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Sandra Ferreyra Vega has authored 13 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 9 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Sandra Ferreyra Vega's work include Glioma Diagnosis and Treatment (13 papers), Epigenetics and DNA Methylation (8 papers) and MicroRNA in disease regulation (4 papers). Sandra Ferreyra Vega is often cited by papers focused on Glioma Diagnosis and Treatment (13 papers), Epigenetics and DNA Methylation (8 papers) and MicroRNA in disease regulation (4 papers). Sandra Ferreyra Vega collaborates with scholars based in Sweden, Norway and Germany. Sandra Ferreyra Vega's co-authors include Helena Carén, Thomas Olsson Bontell, Asgeir Store Jakola, Teresia Kling, Anna Wenger, Anja Smits, Alba Corell, Louise Carstam, Isabella M. Björkman‐Burtscher and Helene Sjögren and has published in prestigious journals such as PLoS ONE, Modern Pathology and BMC Cancer.

In The Last Decade

Sandra Ferreyra Vega

12 papers receiving 250 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Ferreyra Vega Sweden 8 205 111 79 53 48 13 252
Kay Ka-Wai Li China 8 239 1.2× 138 1.2× 82 1.0× 57 1.1× 64 1.3× 10 304
Donatella Bianchessi Italy 9 176 0.9× 122 1.1× 88 1.1× 54 1.0× 77 1.6× 11 306
Nesrine Trabelsi Tunisia 6 159 0.8× 86 0.8× 83 1.1× 40 0.8× 71 1.5× 13 251
Yannick Kerloëguen Switzerland 6 164 0.8× 54 0.5× 47 0.6× 73 1.4× 74 1.5× 10 227
Nellie Yuk‐Fei Chung China 7 276 1.3× 130 1.2× 132 1.7× 77 1.5× 82 1.7× 12 353
Olivier Saulnier France 6 168 0.8× 137 1.2× 83 1.1× 47 0.9× 40 0.8× 11 273
Wolfgang Wick Germany 4 137 0.7× 63 0.6× 54 0.7× 58 1.1× 31 0.6× 10 201
Claire Faulkner United Kingdom 10 204 1.0× 145 1.3× 72 0.9× 29 0.5× 63 1.3× 13 324

Countries citing papers authored by Sandra Ferreyra Vega

Since Specialization
Citations

This map shows the geographic impact of Sandra Ferreyra Vega's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Ferreyra Vega with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Ferreyra Vega more than expected).

Fields of papers citing papers by Sandra Ferreyra Vega

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Ferreyra Vega. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Ferreyra Vega. The network helps show where Sandra Ferreyra Vega may publish in the future.

Co-authorship network of co-authors of Sandra Ferreyra Vega

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Ferreyra Vega. A scholar is included among the top collaborators of Sandra Ferreyra Vega based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Ferreyra Vega. Sandra Ferreyra Vega is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Kling, Teresia, Louise Carstam, Alba Corell, et al.. (2025). CDKN2A/B status versus morphology in diagnosing WHO grade 4 IDH-mutated astrocytomas: what is the clinical relevance?. Journal of Neuro-Oncology. 174(2). 449–458.
2.
Kling, Teresia, et al.. (2024). Refinement of prognostication for IDH‐mutant astrocytomas using DNA methylation‐based classification. Brain Pathology. 34(5). e13233–e13233. 8 indexed citations
3.
Vega, Sandra Ferreyra, Thomas Olsson Bontell, Teresia Kling, Asgeir Store Jakola, & Helena Carén. (2023). Longitudinal DNA methylation analysis of adult-type IDH-mutant gliomas. Acta Neuropathologica Communications. 11(1). 23–23. 5 indexed citations
4.
Bontell, Thomas Olsson, Sandra Ferreyra Vega, Helena Carén, et al.. (2023). The clinical value of proneural, classical and mesenchymal protein signatures in WHO 2021 adult-type diffuse lower-grade gliomas. PLoS ONE. 18(5). e0285732–e0285732. 4 indexed citations
5.
Li, Guanzhang, Jing Feng, Fan Wu, et al.. (2023). Stalled oligodendrocyte differentiation in IDH-mutant gliomas. Genome Medicine. 15(1). 24–24. 18 indexed citations
6.
Pietsch, Torsten, Thomas Olsson Bontell, Teresia Kling, et al.. (2022). DNA methylation profiling improves routine diagnosis of paediatric central nervous system tumours: A prospective population‐based study. Neuropathology and Applied Neurobiology. 48(6). e12838–e12838. 16 indexed citations
7.
Vega, Sandra Ferreyra, Anna Wenger, Teresia Kling, et al.. (2022). Spatial heterogeneity in DNA methylation and chromosomal alterations in diffuse gliomas and meningiomas. Modern Pathology. 35(11). 1551–1561. 12 indexed citations
8.
Corell, Alba, Sandra Ferreyra Vega, Ole Solheim, et al.. (2022). Stemness and clinical features in relation to the subventricular zone in diffuse lower-grade glioma: an exploratory study. Neuro-Oncology Advances. 4(1). vdac074–vdac074. 3 indexed citations
9.
Wenger, Anna, Sandra Ferreyra Vega, Thomas Olsson Bontell, et al.. (2022). DNA methylation alterations across time and space in paediatric brain tumours. Acta Neuropathologica Communications. 10(1). 105–105. 4 indexed citations
10.
Carstam, Louise, Alba Corell, Anja Smits, et al.. (2022). WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade Gliomas. Frontiers in Oncology. 11. 803975–803975. 21 indexed citations
11.
Vega, Sandra Ferreyra, Thomas Olsson Bontell, Alba Corell, et al.. (2021). DNA methylation profiling for molecular classification of adult diffuse lower-grade gliomas. Clinical Epigenetics. 13(1). 102–102. 35 indexed citations
12.
Corell, Alba, Sandra Ferreyra Vega, Louise Carstam, et al.. (2020). The clinical significance of the T2-FLAIR mismatch sign in grade II and III gliomas: a population-based study. BMC Cancer. 20(1). 450–450. 43 indexed citations
13.
Wenger, Anna, Sandra Ferreyra Vega, Teresia Kling, et al.. (2019). Intratumor DNA methylation heterogeneity in glioblastoma: implications for DNA methylation-based classification. Neuro-Oncology. 21(5). 616–627. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026